Key facts
- This page summarizes WuXi AppTec Co., Ltd.'s Form 3 filing for Ambrx Biopharma Inc..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Jan 2023, 17:34.
WuXi AppTec Co., Ltd. - 01 Jan 2023 Form 3 Insider Report for Ambrx Biopharma Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 01 Jan 2023
- Net transaction value
- $0
- Reporting owner signature
- WuXi AppTec Co., Ltd., By: /s/ Edward Hu, Director
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
WuXi AppTec Co., Ltd. filed Form 3 for Ambrx Biopharma Inc. on 09 Jan 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMAM
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 21,270,767
- Date
- 01 Jan 2023
- Ownership
- Held by WuXi PharmaTech Healthcare Fund I, L.P.
- Footnotes
- F1, F2
AMAM
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,996,920
- Date
- 01 Jan 2023
- Ownership
- Held by WuXi AppTec (Hong Kong) Holding Limited
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares of the Issuer.
Footnote F2
Shares are directly held by WuXi PharmaTech Healthcare Fund I, L.P. ("PharmaTech"). PharmaTech is an indirect, wholly owned subsidiary of WuXi AppTec Co., Ltd. ("AppTec Co"), which is the ultimate beneficial owner of PharmaTech and shares voting and investment authority over these shares.
Footnote F3
Shares are directly held by WuXi AppTec (Hong Kong) Holding Limited ("AppTec HK"). AppTec HK is an indirect, wholly owned subsidiary of AppTec Co, which is the ultimate beneficial owner of AppTec HK and shares voting and investment authority over these shares.